CABINET Allergy Relief
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68210-0119 -
Package NDC
68210-0119-0 -
Package NDC
68210-0119-1 -
Package NDC
68210-0119-3 -
Application number
ANDA209274 -
SPL ID
2a804c42-e22a-703e-e063-6394a90a3b1b -
SPL set ID
e49c3c91-aab8-478e-97fa-04ed06180021 -
UNII
64O047KTOA -
RxCUI
1014678
What the source publishes
- Labeler
- Spirit Pharmaceutical LLC
- Active ingredients
- Cetirizine Hydrochloride
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
Complete source data
{
"name": "CABINET Allergy Relief",
"splId": "2a804c42-e22a-703e-e063-6394a90a3b1b",
"labels": [
{
"setId": "e49c3c91-aab8-478e-97fa-04ed06180021",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e49c3c91-aab8-478e-97fa-04ed06180021",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e49c3c91-aab8-478e-97fa-04ed06180021"
}
],
"routes": [
"ORAL"
],
"labeler": "Spirit Pharmaceutical LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68210-0119-0)",
"package_ndc": "68210-0119-0",
"identifierStatus": "well-formed",
"marketing_start_date": "20191025"
},
{
"sample": false,
"description": "300 TABLET, FILM COATED in 1 BOTTLE (68210-0119-1)",
"package_ndc": "68210-0119-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20200310"
},
{
"sample": false,
"description": "1 BOTTLE, PLASTIC in 1 CARTON (68210-0119-3) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
"package_ndc": "68210-0119-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20200310"
}
],
"productId": "68210-0119_2a804c42-e22a-703e-e063-6394a90a3b1b",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "68210-0119",
"deaSchedule": null,
"genericName": "Cetirizine Hydrochloride",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CETIRIZINE HYDROCHLORIDE",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA209274",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20191025",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"unii": [
"64O047KTOA"
],
"rxcui": [
"1014678"
],
"spl_set_id": [
"e49c3c91-aab8-478e-97fa-04ed06180021"
],
"manufacturer_name": [
"Spirit Pharmaceutical LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68210-0119_2a804c42-e22a-703e-e063-6394a90a3b1b"